not losing weight on tirzepatide 2.5 Before and After Results: Loss Timelines (2026) Why am I not losing

How do we personalize dosing

According to FDA prescribing information, gastrointestinal adverse events are among the most commonly reported side effects, with constipation affecting a significant proportion of patients, particularly during dose escalation phases

Tirepatide often leads to reduced calorie intake, as it naturally suppresses appetite and helps the energy from meals last longer

Mysimba tablets should only be taken by adults over the age of 18 who have a body mass index (BMI) of 30 and above, which would place them into the obese category

Its short half-life is a feature, not a limitation, preserving the physiologic pulsatility of GH secretion

Commun Med (Lond)